Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

An Tang, Matthew Mcinnes, Thomas A. Hope, Kim Nhien Vu, Devendra Amre, Tanya Wolfson, Chantal Roy, Benoît R. Mâsse, Claude Sirlin

Research output: Contribution to journalArticle

Abstract

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

Original languageEnglish (US)
Article numberCD012766
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number8
DOIs
StatePublished - Aug 21 2017
Externally publishedYes

Fingerprint

Routine Diagnostic Tests
Contrast Media
Liver Diseases
Hepatocellular Carcinoma
Chronic Disease
Magnetic Resonance Imaging
gadolinium ethoxybenzyl DTPA

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. / Tang, An; Mcinnes, Matthew; Hope, Thomas A.; Vu, Kim Nhien; Amre, Devendra; Wolfson, Tanya; Roy, Chantal; Mâsse, Benoît R.; Sirlin, Claude.

In: Cochrane Database of Systematic Reviews, Vol. 2017, No. 8, CD012766, 21.08.2017.

Research output: Contribution to journalArticle

Tang, An ; Mcinnes, Matthew ; Hope, Thomas A. ; Vu, Kim Nhien ; Amre, Devendra ; Wolfson, Tanya ; Roy, Chantal ; Mâsse, Benoît R. ; Sirlin, Claude. / Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. In: Cochrane Database of Systematic Reviews. 2017 ; Vol. 2017, No. 8.
@article{1ab875740a744a87baeb61cc86fdbc1e,
title = "Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients",
abstract = "This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.",
author = "An Tang and Matthew Mcinnes and Hope, {Thomas A.} and Vu, {Kim Nhien} and Devendra Amre and Tanya Wolfson and Chantal Roy and M{\^a}sse, {Beno{\^i}t R.} and Claude Sirlin",
year = "2017",
month = "8",
day = "21",
doi = "10.1002/14651858.CD012766",
language = "English (US)",
volume = "2017",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Magnetic resonance imaging performed with gadoxetate disodium for the diagnosis of hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

AU - Tang, An

AU - Mcinnes, Matthew

AU - Hope, Thomas A.

AU - Vu, Kim Nhien

AU - Amre, Devendra

AU - Wolfson, Tanya

AU - Roy, Chantal

AU - Mâsse, Benoît R.

AU - Sirlin, Claude

PY - 2017/8/21

Y1 - 2017/8/21

N2 - This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

AB - This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To determine the per-lesion and per-person diagnostic accuracy of magnetic resonance imaging (MRI) performed with gadoxetate disodium for the diagnosis of HCC in people with chronic liver disease. To identify factors that influence the reported diagnostic performance of hepatobiliary contrast agents.

UR - http://www.scopus.com/inward/record.url?scp=85027723118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027723118&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012766

DO - 10.1002/14651858.CD012766

M3 - Article

VL - 2017

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 8

M1 - CD012766

ER -